Skip to content

GLP-1 Users Lost Sight in the Second Eye Sooner, Ophthalmology Study Finds as Vision-Loss Lawsuits Grow — October 08, 2026

October 8, 2026 · 11 min

Show notes

An American Academy of Ophthalmology meeting study links GLP-1 use to faster second-eye NAION, as federal eye-injury cases climb to 247; plus Medicare Bridge paperwork gaps for cash-pay patients, pharmacists seeing more cash GLP-1 fills, the WHO's first childhood obesity guidelines, and Korea's first homegrown GLP-1 obesity drug.

In this episode
  1. GLP-1 Drugs Linked to Faster Vision Loss in the Second Eye, New Study Finds | Newswise — American Academy of Ophthalmology (AAO

    GLP-1 Drugs Linked to Faster Vision Loss in the Second Eye, New Study Finds | Newswise # GLP-1 Drugs Linked to Faster Vision Loss in the Second Eye, New Study Finds ###### Among patients who suffered a rare optic nerve stroke in both eyes, those taking GLP-1 drugs saw the second eye affected sooner. They caution that causation hasn’t been established, only an association. 6-Oct-2026 at 9:30…

  2. Medicare’s Missing On-Ramp For Access To GLP-1s For Weight Management | Health Affairs — T. Joseph Mattingly II

    Medicare’s Missing On-Ramp For Access To GLP-1s For Weight Management | Health Affairs # Medicare’s Missing On-Ramp For Access To GLP-1s For Weight Management - T. Joseph Mattingly II, - Rena M. Conti, - and - Sean D. Sullivan October 7, 2026 Medicare’s GLP-1 Bridge program is off to a fast start, but gaps in prior authorization design may exclude beneficiaries who began GLP-1 therapy…

  3. Patients increasingly bypass insurance to pay cash for GLP-1 prescriptions, pharmacists say — Bill Schiffner

    Patients increasingly bypass insurance to pay cash for GLP-1 prescriptions, pharmacists say # Patients increasingly bypass insurance to pay cash for GLP-1 prescriptions, pharmacists say The trend reflects the rapidly evolving GLP-1 marketplace. , and Bill Schiffner October 7, 2026 . 10:06 AM HIALEAH, Fla. — A growing number of patients are choosing to pay cash for GLP-1 medications…

  4. Should kids living with obesity be on GLP-1s? New global guidance says yes — in some cases — CBC News

    Should kids living with obesity be on GLP-1s? New global guidance says yes — in some cases ## Should kids living with obesity be on GLP-1s? New global guidance says yes — in some cases New Lauren Pelley | CBC News | Posted: October 7, 2026 8:00 AM | Last Updated: Just now World Health Organization has released its first-ever guidelines on managing childhood obesity Image | VANCOUVER NEW…

  5. MFDS approves Hanmi's EPPE, Korea's first homegrown GLP-1 obesity drug · Local Chorus — Local Chorus

    MFDS approves Hanmi's EPPE, Korea's first homegrown GLP-1 obesity drug · Local Chorus # MFDS approves Hanmi's EPPE, Korea's first homegrown GLP-1 obesity drug 🇰🇷 South Korea, Seoul 09:37 Health Business 8 Official updated 2 h ago first reported by 서울경제 Copy link ## In short Korea's Ministry of Food and Drug Safety approved Hanmi Pharmaceutical's EPPE auto-injector (efpeglenatide) on Oct 7,…

Daily TopFive for GLP-1 Daily: Ozempic & Wegovy News. Links above go to the original articles. Follow and rate GLP-1 Daily: Ozempic & Wegovy News on Apple Podcasts. Feedback? Email [email protected].

All episodes of GLP-1 Daily: Ozempic & Wegovy News

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.